The well-known investment firm Royalty Pharma has just announced its intention of buying royalties on Vertex Pharmaceuticals Inc.’s cystic fibrosis drug, Kalydeco. Kalydeco received its Food and Drug Administration approval in January 2012 after being co-developed with the help of the Cystic Fibrosis Foundation. This deal is planned to fund further therapies for the disease, Royal Pharma … [Read more...]
Muscular dystrophy first ever drug wins approval from EU
A drug for treating a particular form of Duchenne muscular dystrophy has surprisingly got approval from the European Medicines Agency. The Muscular-dystrophy drug results in rise of stock up to 50% in early afternoon. Earlier the stock rose more than 70%. The drug is presumed to be in stock in UK in six months. On the basis of phase-two data the Committee for Medicinal Products for … [Read more...]